245 related articles for article (PubMed ID: 32221685)
1. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.
Samiei S; Smidt ML; Vanwetswinkel S; Engelen SME; Schipper RJ; Lobbes MBI; van Nijnatten TJA
Eur Radiol; 2020 Aug; 30(8):4212-4222. PubMed ID: 32221685
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
Samiei S; van Nijnatten TJA; van Beek HC; Polak MPJ; Maaskant-Braat AJG; Heuts EM; van Kuijk SMJ; Schipper RJ; Lobbes MBI; Smidt ML
Sci Rep; 2019 Nov; 9(1):17476. PubMed ID: 31767929
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study.
van Nijnatten TJA; Schipper RJ; Lobbes MBI; van Roozendaal LM; Vöö S; Moossdorff M; Paiman ML; de Vries B; Keymeulen KBMI; Wildberger JE; Smidt ML; Beets-Tan RGH
Clin Radiol; 2018 Feb; 73(2):168-175. PubMed ID: 29029766
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of standard breast MR imaging compared to dedicated axillary MR imaging in the evaluation of axillary lymph node.
Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
BMC Med Imaging; 2020 May; 20(1):45. PubMed ID: 32357942
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of T2-weighted imaging and intravoxel incoherent motion diffusion-weighted MRI for predicting metastatic axillary lymph nodes in T1 and T2 stage breast cancer.
Liu Y; Luo H; Wang C; Chen X; Wang M; Zhou P; Ren J
Acta Radiol; 2022 Apr; 63(4):447-457. PubMed ID: 33779304
[TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
de Mooij CM; Samiei S; Mitea C; Lobbes MBI; Kooreman LFS; Heuts EM; Beets-Tan RGH; van Nijnatten TJA; Smidt ML
Clin Radiol; 2022 Oct; 77(10):e732-e740. PubMed ID: 35850866
[TBL] [Abstract][Full Text] [Related]
9. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
10. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
[TBL] [Abstract][Full Text] [Related]
13. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer.
Zhao M; Wu Q; Guo L; Zhou L; Fu K
Eur J Radiol; 2020 Aug; 129():109093. PubMed ID: 32512504
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
17. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients.
Dulgeroglu O; Arikan AE; Capkinoglu E; Kara H; Uras C
Ann Ital Chir; 2022; 93():648-655. PubMed ID: 36617275
[TBL] [Abstract][Full Text] [Related]
19. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
20. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]